Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Cuspidi

Showing results (301-310 of 353) with videos related to

Pageof 36
Sort By:
Blood Pressure Monitoring|November 21, 2008
Body mass index, nocturnal fall in blood pressure and organ damage in untreated essential hypertensive patientsCesare Cuspidi, Stefano Meani, Cristiana Valerio, et al.
Journal of Hypertension|March 19, 2005
Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension studyCesare Cuspidi, Stefano Meani, Veronica Fusi, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|November 1, 2002
Trends in hypertension control and left ventricular hypertrophy over three yearsCesare Cuspidi, Iassen Michey, Stefano Meani, et al.
Circulation|September 10, 2009
Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA)Alberto Zanchetti, Michael Hennig, Regina Hollweck, et al.
Journal of Hypertension|September 14, 2013
Does a nondipping pattern influence left ventricular and left atrial mechanics in hypertensive patients?Marijana Tadic, Cesare Cuspidi, Anka Majstorovic, et al.
Blood Pressure|March 11, 2011
Aortic root dilatation in hypertensive patients: a multicenter survey in echocardiographic practiceCesare Cuspidi, Francesca Negri, Massimo Salvetti, et al.
Blood Pressure|April 16, 2004
High prevalence of retinal vascular changes in never-treated essential hypertensives: an inter- and intra-observer reproducibility study with non-mydriatic retinographyCesare Cuspidi, Maurizio Salerno, Daniela E Salerno, et al.
Journal of the American Society of Hypertension : JASH|February 3, 2016
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertensionGino Seravalle, Gianmaria Brambilla, Daniela Prata Pizzalla, et al.
Journal of Hypertension|March 6, 2009
Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalaprilMichele M Ciulla, Roberta Paliotti, Arturo Esposito, et al.
Journal of Hypertension|November 1, 2002
Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) studyCesare Cuspidi, M Lorenza Muiesan, Laura Valagussa, et al.
Pageof 36

Showing results (301-310 of 353) with videos related to

Sort By:
Pageof 36
Blood Pressure Monitoring|November 21, 2008
Body mass index, nocturnal fall in blood pressure and organ damage in untreated essential hypertensive patientsCesare Cuspidi, Stefano Meani, Cristiana Valerio, et al.
Journal of Hypertension|March 19, 2005
Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension studyCesare Cuspidi, Stefano Meani, Veronica Fusi, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|November 1, 2002
Trends in hypertension control and left ventricular hypertrophy over three yearsCesare Cuspidi, Iassen Michey, Stefano Meani, et al.
Circulation|September 10, 2009
Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA)Alberto Zanchetti, Michael Hennig, Regina Hollweck, et al.
Journal of Hypertension|September 14, 2013
Does a nondipping pattern influence left ventricular and left atrial mechanics in hypertensive patients?Marijana Tadic, Cesare Cuspidi, Anka Majstorovic, et al.
Blood Pressure|March 11, 2011
Aortic root dilatation in hypertensive patients: a multicenter survey in echocardiographic practiceCesare Cuspidi, Francesca Negri, Massimo Salvetti, et al.
Blood Pressure|April 16, 2004
High prevalence of retinal vascular changes in never-treated essential hypertensives: an inter- and intra-observer reproducibility study with non-mydriatic retinographyCesare Cuspidi, Maurizio Salerno, Daniela E Salerno, et al.
Journal of the American Society of Hypertension : JASH|February 3, 2016
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertensionGino Seravalle, Gianmaria Brambilla, Daniela Prata Pizzalla, et al.
Journal of Hypertension|March 6, 2009
Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalaprilMichele M Ciulla, Roberta Paliotti, Arturo Esposito, et al.
Journal of Hypertension|November 1, 2002
Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) studyCesare Cuspidi, M Lorenza Muiesan, Laura Valagussa, et al.
Pageof 36